FDA orders recall of intravenous pumps

The Food and Drug Administration announced the recall of 206,000 infusion pumps after three people died and six became seriously ill when the pumps shut down unexpectedly. The Baxter International Colleague volumetric infusion pumps stopped working for a variety of software, wiring and design reasons. Because some hospitals use only this brand of infusion pumps, the agency is asking users to employ other machines in critical cases and to monitor the machines closely.  The agency termed the recall Class 1, its most serious classification.

- read this report from The New York Times for more

Suggested Articles

As Relay looks to enter the clinic in 2020, the company is adding a trio of biopharma vets to its leadership team.

A phase 3 trial of Myovant Sciences’ relugolix in prostate cancer has met its primary endpoint, teeing the company up to file for FDA approval.

The Medicines Company, fresh from its turn at the AHA this weekend, has seen its shares jump on growing rumors that Novartis wants to acquire it.